A Clinical Study Assessing Use of Letermovir (LTV) for Cytomegalovirus (CMV) Prophylaxis or Treatment and Clinical Outcomes in Adult Thoracic Solid Organ Transplant (SOT) Recipients
Latest Information Update: 14 Jul 2020
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections; Cytomegalovirus retinitis; Viraemia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Jul 2020 New trial record
- 03 Jun 2020 Results assessing use of letermovir for cytomegalovirus management in thoracic organ transplantation, were presented at the 2020 American Transplant Congress.